INTERPACE BIOSCIENCES, INC. Deferred Tax Assets, Operating Loss Carryforwards
INTERPACE BIOSCIENCES, INC. (IDXGD) had Deferred Tax Assets, Operating Loss Carryforwards of $21.59 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $21.59M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $24.15M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $25.01M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $26.43M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $26.71M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $21.59M 10-K · filed 2026-03-30 | |
| 2024-12-31 | $24.15M 10-K · filed 2026-03-30 | |
| 2023-12-31 | $25.01M 10-K · filed 2025-03-31 | $26.43M 10-K · filed 2024-04-01 |
| 2022-12-31 | $26.71M 10-K · filed 2024-04-01 | |
| 2021-12-31 | $24.92M 10-K · filed 2023-03-27 | |
| 2020-12-31 | $17.02M 10-K · filed 2022-03-31 | |
| 2019-12-31 | $11.66M 10-K · filed 2021-04-01 | $44.15M 10-K · filed 2020-04-22 |
| 2018-12-31 | $40.16M 10-K/A · filed 2021-01-19 | |
| 2017-12-31 | $31.94M 10-K · filed 2019-03-21 | |
| 2016-12-31 | $51.69M 10-K · filed 2018-03-23 | |
| 2015-12-31 | $46.17M 10-K · filed 2017-03-31 | |
| 2014-12-31 | $41.47M 10-K · filed 2016-03-30 | |
| 2013-12-31 | $31.25M 10-K · filed 2015-03-05 | -$31.25M 10-K · filed 2014-03-06 |
| 2012-12-31 | -$28.61M 10-K · filed 2014-03-06 | |
| 2011-12-31 | -$24.74M 10-K · filed 2013-03-15 |